Deborah A Gill, MD
Ophthalmology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Gill’s office at (415) 833-3780 to ask if they take your plan before you enroll.
California Medical Board record
Licence A92607 · Current
Licensed to practise in California · since 2005 · expires 2026-12-31 · University of Pennsylvania School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$1,034
Medicare paid this office $1,034 for 14 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Who their Medicare patients are
14 Original Medicare patients in 2024. Average age 69 · 85 and older 0% · Health risk score 1.27. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
The office billed $3,962, Medicare allowed $1,908 and paid $1,034; for 22 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 14 | 22 | 69 | 1.27 | $3,962 | $1,034 |
| 2018 | 15 | 21 | 73 | 1.48 | $5,783 | $2,081 |
| 2017 | 19 | 29 | 69 | 1.06 | $14,233 | $3,006 |
| 2016 | 20 | 32 | 65 | 1.33 | $20,136 | $4,652 |
| 2014 | 12 | 19 | 69 | 2.01 | $17,181 | $3,600 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2017: 1 service
| Established patient problem focused exam of visual system | 11 | $688 | $57 |
2016: 1 service
| Established patient problem focused exam of visual system | 12 | $665 | $48 |
Medicaid work
$1,640 in 2024
Medicaid paid $1,640 for 13 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 13 | $1,640 |
| 2024 | 13 | 1 | 13 | $1,640 |
Drugs they prescribed that Part D paid
$45,709
Pharmacies billed $45,709 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 914) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
599 generic and 315 brand-name prescriptions · $45,709 in drug cost · 14 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prednisolone Acetate | 218 | $11,700 | $54 |
| Cyclosporine | 64 | $6,030 | $94 |
| Latanoprost | 202 | $3,087 | $15 |
| Dorzolamide-Timolol | 97 | $2,525 | $26 |
| Brimonidine | 85 | $2,024 | $24 |
See all 12 drugs
| Prednisolone Acetate | 218 | $11,700 | $54 |
| Cyclosporine | 64 | $6,030 | $94 |
| Latanoprost | 202 | $3,087 | $15 |
| Dorzolamide-Timolol | 97 | $2,525 | $26 |
| Brimonidine | 85 | $2,024 | $24 |
| Timolol Maleate | 39 | $832 | $21 |
| Dorzolamide | 32 | $796 | $25 |
| Diclofenac | 45 | $589 | $13 |
| Atropine Sulfate | 15 | $476 | $32 |
| Doxycycline Monohydrate | 11 | $334 | $30 |
| Ofloxacin | 14 | $279 | $20 |
| Neomycin-Polymyxin-Dexameth | 16 | $243 | $15 |
Year by year
| 2024 | 914 | 324 | 0% (0) | 34% | $45,709 |
| 2023 | 1,004 | 342 | 0% (0) | 37% | $57,785 |
| 2022 | 1,009 | 312 | 0% (0) | 38% | $64,485 |
| 2021 | 937 | 289 | 0% (0) | 30% | $72,255 |
| 2020 | 872 | 265 | 0% (0) | 22% | $52,275 |
| 2019 | 1,230 | 406 | 0% (0) | 29% | $79,149 |
| 2018 | 1,247 | 425 | 0% (0) | 33% | $79,386 |
| 2017 | 1,531 | 459 | 0% (0) | 37% | $107,391 |
| 2016 | 1,439 | 458 | 0% (0) | 37% | $84,905 |
| 2015 | 1,546 | 391 | 0% (0) | 45% | $101,469 |
| 2014 | 1,699 | 428 | None | 41% | $100,340 |
| 2013 | 1,940 | 468 | None | None | $89,232 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Prednisolone Acetate | 259 | $13,591 | $52 |
| Cyclosporine | 59 | $6,076 | $103 |
| Nevanac | 14 | $4,842 | $346 |
| Latanoprost | 195 | $2,984 | $15 |
| Dorzolamide-Timolol | 105 | $2,816 | $27 |
| Brimonidine | 96 | $2,671 | $28 |
| Timolol Maleate | 45 | $2,415 | $54 |
| Dorzolamide | 47 | $1,031 | $22 |
| Diclofenac | 58 | $798 | $14 |
| Ofloxacin | 25 | $427 | $17 |
2022: 14 drugs
| Cequa | 36 | $14,376 | $399 |
| Prednisolone Acetate | 249 | $12,899 | $52 |
| Zirgan | 11 | $5,170 | $470 |
| Nevanac | 15 | $4,567 | $304 |
| Latanoprost | 207 | $3,685 | $18 |
| Brimonidine | 92 | $3,421 | $37 |
| Dorzolamide-Timolol | 113 | $3,092 | $27 |
| Cyclosporine | 11 | $1,926 | $175 |
| Timolol Maleate | 40 | $1,661 | $42 |
| Dorzolamide | 55 | $1,274 | $23 |
| Diclofenac | 56 | $783 | $14 |
| Atropine Sulfate | 11 | $420 | $38 |
| Ofloxacin | 19 | $299 | $16 |
| Moxifloxacin | 11 | $132 | $12 |
2021: 10 drugs
| Cequa | 55 | $28,177 | $512 |
| Prednisolone Acetate | 188 | $16,399 | $87 |
| Latanoprost | 229 | $4,228 | $18 |
| Dorzolamide-Timolol | 123 | $4,147 | $34 |
| Brimonidine | 90 | $1,658 | $18 |
| Timolol Maleate | 51 | $1,651 | $32 |
| Dorzolamide | 46 | $1,310 | $28 |
| Diclofenac | 35 | $521 | $15 |
| Ofloxacin | 27 | $467 | $17 |
| Neomycin-Polymyxin-Dexameth | 14 | $195 | $14 |
2020: 10 drugs
| Restasis | 29 | $19,204 | $662 |
| Prednisolone Acetate | 134 | $6,870 | $51 |
| Latanoprost | 236 | $5,404 | $23 |
| Dorzolamide-Timolol | 112 | $4,877 | $44 |
| Timolol Maleate | 61 | $2,168 | $36 |
| Dorzolamide | 41 | $1,355 | $33 |
| Brimonidine | 73 | $1,311 | $18 |
| Ofloxacin | 59 | $1,020 | $17 |
| Diclofenac | 27 | $472 | $17 |
| Neomycin-Polymyxin-Dexameth | 18 | $235 | $13 |
2019: 15 drugs
| Restasis | 40 | $26,165 | $654 |
| Prednisolone Acetate | 238 | $13,074 | $55 |
| Latanoprost | 273 | $5,403 | $20 |
| Dorzolamide-Timolol | 103 | $4,353 | $42 |
| Fluorometholone | 23 | $2,520 | $110 |
| Dexamethasone Sodium Phosphate | 22 | $1,762 | $80 |
| Polymyxin B Sul-Trimethoprim | 131 | $1,564 | $12 |
| Dorzolamide | 41 | $1,356 | $33 |
| Ofloxacin | 64 | $1,355 | $21 |
| Bacitracin | 11 | $1,334 | $121 |
| Brimonidine | 71 | $1,241 | $17 |
| Timolol Maleate | 55 | $1,165 | $21 |
| Neomycin-Polymyxin-Dexameth | 31 | $581 | $19 |
| Diclofenac | 31 | $532 | $17 |
| Erythromycin | 12 | $258 | $21 |
2018: 14 drugs
| Restasis | 42 | $22,643 | $539 |
| Prednisolone Acetate | 286 | $21,082 | $74 |
| Latanoprost | 217 | $5,767 | $27 |
| Dorzolamide-Timolol | 99 | $2,671 | $27 |
| Polymyxin B Sul-Trimethoprim | 184 | $2,174 | $12 |
| Atropine Sulfate | 25 | $1,754 | $70 |
| Bacitracin | 15 | $1,737 | $116 |
| Fluorometholone | 16 | $1,687 | $105 |
| Brimonidine | 82 | $1,444 | $18 |
| Diclofenac | 40 | $927 | $23 |
| Timolol Maleate | 55 | $895 | $16 |
| Dorzolamide | 28 | $788 | $28 |
| Ofloxacin | 24 | $771 | $32 |
| Neomycin-Polymyxin-Dexameth | 32 | $671 | $21 |
2017: 15 drugs
| Prednisolone Acetate | 352 | $24,857 | $71 |
| Restasis | 43 | $23,682 | $551 |
| Gatifloxacin | 172 | $8,145 | $47 |
| Latanoprost | 229 | $5,909 | $26 |
| Zymaxid | 29 | $3,589 | $124 |
| Diclofenac | 162 | $3,430 | $21 |
| Dorzolamide-Timolol | 107 | $3,140 | $29 |
| Atropine Sulfate | 41 | $3,075 | $75 |
| Brimonidine | 70 | $2,281 | $33 |
| Dorzolamide | 41 | $1,051 | $26 |
| Timolol Maleate | 47 | $863 | $18 |
| Polymyxin B Sul-Trimethoprim | 76 | $837 | $11 |
| Acyclovir | 13 | $669 | $51 |
| Neomycin-Polymyxin-Dexameth | 28 | $630 | $23 |
| Ofloxacin | 15 | $378 | $25 |
2016: 17 drugs
| Prednisolone Acetate | 275 | $18,884 | $69 |
| Restasis | 30 | $13,463 | $449 |
| Zymaxid | 126 | $9,087 | $72 |
| Latanoprost | 276 | $6,902 | $25 |
| Diclofenac | 170 | $4,010 | $24 |
| Brimonidine | 64 | $3,400 | $53 |
| Dorzolamide-Timolol | 79 | $2,553 | $32 |
| Dorzolamide | 67 | $2,072 | $31 |
| Bacitracin | 14 | $1,647 | $118 |
| Timolol Maleate | 70 | $1,373 | $20 |
| Ofloxacin | 74 | $1,045 | $14 |
| Atropine Sulfate | 27 | $967 | $36 |
| Acyclovir | 11 | $568 | $52 |
| Neomycin-Polymyxin-Dexameth | 19 | $354 | $19 |
| Levobunolol | 18 | $318 | $18 |
| Erythromycin | 12 | $209 | $17 |
| Polymyxin B Sul-Trimethoprim | 15 | $140 | $9 |
2015: 12 drugs
| Zymaxid | 276 | $25,441 | $92 |
| Prednisolone Acetate | 332 | $23,085 | $70 |
| Restasis | 53 | $20,865 | $394 |
| Latanoprost | 343 | $8,456 | $25 |
| Diclofenac | 274 | $6,296 | $23 |
| Brimonidine | 42 | $2,236 | $53 |
| Timolol Maleate | 40 | $1,749 | $44 |
| Bacitracin | 15 | $1,424 | $95 |
| Dorzolamide | 44 | $1,123 | $26 |
| Dorzolamide-Timolol | 13 | $313 | $24 |
| Ofloxacin | 18 | $198 | $11 |
| Polymyxin B Sul-Trimethoprim | 11 | $103 | $9 |
2014: 11 drugs
| Prednisolone Acetate | 328 | $23,322 | $71 |
| Zymaxid | 255 | $22,210 | $87 |
| Restasis | 40 | $15,719 | $393 |
| Latanoprost | 301 | $7,738 | $26 |
| Diclofenac | 328 | $4,902 | $15 |
| Dorzolamide | 129 | $4,543 | $35 |
| Azopt | 11 | $3,852 | $350 |
| Timolol Maleate | 109 | $3,850 | $35 |
| Brimonidine | 63 | $2,380 | $38 |
| Dorzolamide-Timolol | 21 | $873 | $42 |
| Levobunolol | 33 | $637 | $19 |
2013: 13 drugs
| Zymaxid | 335 | $24,344 | $73 |
| Prednisolone Acetate | 375 | $12,640 | $34 |
| Restasis | 30 | $9,694 | $323 |
| Latanoprost | 270 | $6,945 | $26 |
| Dorzolamide | 144 | $5,947 | $41 |
| Diclofenac | 390 | $5,704 | $15 |
| Azopt | 11 | $3,808 | $346 |
| Timolol Maleate | 123 | $3,177 | $26 |
| Brimonidine | 85 | $1,779 | $21 |
| Levobunolol | 48 | $951 | $20 |
| Dorzolamide-Timolol | 17 | $763 | $45 |
| Neomycin-Polymyxin-Dexameth | 18 | $365 | $20 |
| Polymyxin B Sul-Trimethoprim | 12 | $125 | $10 |
Money from drug and device companies
$100 in 2025
| 2025 | 2 | 4 | None | $100 |
| 2024 | 2 | 4 | None | $276 |
| 2023 | 3 | 5 | None | $522 |
| 2022 | 1 | 1 | None | $152 |
| 2020 | 1 | 1 | None | $32 |
| 2019 | 1 | 4 | None | $245 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Clareon | $70 | 3 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $30 | 1 payment
|
See all 4 published payments
| Alcon Vision | Meals · 2025-11-19 | Clareon | $17 |
| Alcon Vision | Meals · 2025-11-10 | Clareon | $28 |
| Johnson & Johnson Surgical Vision | Meals · 2025-06-06 | Tecnis Iol | $30 |
| Alcon Vision | Meals · 2025-04-04 | Clareon | $24 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $276
| Alcon Vision | Clareon | $242 | 3 payments
|
| Abbvie | Xen Glaucoma Treatment System | $34 | 1 payment
|
2023: $522
| Alcon Vision | Clareon | $419 | 3 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $66 | 1 payment
|
| Carl Zeiss Meditec | None | $36 | 1 payment
|
2022: $152
| Alcon Vision | Clareon | $152 | 1 payment
|
2020: $32
| Alcon Vision | Luxor | $32 | 1 payment
|
2019: $245
| Alcon Vision | Restor | $245 | 4 payments
|
Professional record
- NPI
- 1346353406
- Licence
- CA A92607California A92607: Current · expires 2026-12-31
- Trained
- Perelman School of Med at the University of Pennsylvania, 2001
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 710 Lawrence Expy, Dept. 490, Santa Clara, CA, 95051
- NPI first listed
- 2006-08-15
- NPI last updated
- 2021-12-09
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.